This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction. The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness

E. Sherwood Brown, MD, PhD

Published: July 14, 2006

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

The course and treatment of severe mental illness canbe complicated by the co-occurrence of substance use disorders. According to the Epidemiologic CatchmentArea study,1 47% of those with schizophrenia and 56% ofthose with any bipolar disorder meet the criteria for substanceabuse or dependence at some point during their life.Patients with the dual diagnosis of substance use andschizophrenia tend to have an earlier age at onset and experiencemore frequent and longer periods of hospitalization,have more depressive and psychotic symptoms, andhave more episodes of suicidal behavior, violence, and legaland financial problems than those who do not use orabuse drugs or alcohol.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Comorbidity , Medical

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...